BKS-2 is an immature B cell lymphoma that undergoes apoptotic cell dea
th when signaled via its surface IgM receptor. To study the signaling
components of surface IgM mediated apoptosis in B lymphoma cells, we g
enerated mutants of BKS-2 that were resistant to anti-IgM induced apop
tosis. One mutant cell line, 1.B5, did not undergo apoptotic cell deat
h upon treatment with anti-IgM antibodies and also did not exhibit ele
vation of intracellular Ca2+ in response to cross-linking of surface I
gM. This appeared to be due to a defect in protein tyrosine kinase (PT
K) activity since fewer proteins were tyrosine phosphorylated in the m
utant cells stimulated with anti-IgM when compared to wild type BKS-2.
Subsequently, we showed that protein tyrosine kinases lyn and blk wer
e inducibly tyrosine phosphorylated in the wild type BKS-2 but not in
1.B5 mutant cells in response to anti-IgM. Also the kinase activity of
lyn was elevated in the wild type but not in mutant cells upon trigge
ring through surface IgM. Furthermore, tyrosine phosphorylation of CD
19, a known substrate of lyn, was inducible in anti-IgM stimulated BKS
-2 cells but severely reduced in 1.B5 cells. In contrast, kinase activ
ity of another src kinase, blk, was increased on anti-IgM stimulation
in both wild type and mutant cells. Surprisingly, syk, a non-src prote
in tyrosine kinase important for surface IgM mediated signaling, was t
yrosine phosphorylated in the lyn deficient mutant cells as well as in
the wild type BKS-2 cells. Furthermore, anti-IgM induced increase in
kinase activity of syk was similar in the mutant and wild type cells.
Thus, in contrast to other studies that propose syk to be a downstream
target of src family kinases, syk may act upstream of lyn in immature
B cells. Consistent with a functional syk, its target, phospholipase
gamma 2 (PLC-gamma 2) was normally tyrosine phosphorylated in mutant c
ells. (C) 1998 Elsevier Science Ltd. All rights reserved.